The U.S. Securities and Exchange Commission (SEC) has announced that it will allow companies who supply vaccines to U.S. government stockpile programs to recognize revenue on delivery instead of waiting for vaccines to be used.Reed stated, I am pleased with the SECs decision and hope that companies are encouraged to continue participating in federal stockpile programs to ensure that we have a ready supply of vaccines on hand. Congress, the Administration, medical providers and manufacturers must continue to work together to ensure an adequate and reliable supply of vaccines.In November, Reed sent a letter to the SEC requesting an update from the agency regarding stockpile accounting issues.A copy of the letter follows:November 22, 2005The Honorable Christopher C. CoxChairman U.S. Securities and Exchange Commission100 F Street NEWashington, DC 20549Dear Chairman Cox:The Committee on Health, Education, Labor, and Pensions (HELP Committee) has been working with the Department of Health and Human Services (HHS) to ensure the safety and completeness of our nations vaccine stockpiles. As members of the HELP Committee and of the Committee on Banking, Housing and Urban Affairs, we believe the recent discussions between the Department and SEC staff regarding stockpile accounting issues were essential for both agencies to thoroughly review any potential impediments to the participation by certain vaccine manufactures in the Federal Pediatric Vaccine Stockpile program. We understand that the SEC has been working with each of the vaccine manufacturers involved, in addition to the meetings with HHS and the Center for Disease Control, to determine what are the issues facing the manufactures and how the SEC can be helpful in their resolution. We would appreciate an update on this matter, including any future plan of action by the Commission.Thank you for your attention to this important matter. Sincerely,Sen. Jack Reed